This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988 Jan;1(5):441-6.

doi: 10.1007/BF02125729.

Interaction between Ca2+ antagonists and digitalis

J N Lessem¹

Affiliations

PMID: 3154676
DOI: 10.1007/BF02125729

Interaction between Ca2+ antagonists and digitalis

J N Lessem. Cardiovasc Drugs Ther. 1988 Jan.

. 1988 Jan;1(5):441-6.

doi: 10.1007/BF02125729.

Author

J N Lessem¹

Affiliation

¹ Institute of Clinical Medicine, Syntex Research, Palo Alto, California 94301.

PMID: 3154676
DOI: 10.1007/BF02125729

No abstract available

PubMed Disclaimer

Similar articles

Comparison of the effects of calcium channel blockers and antiarrhythmic drugs on digitalis-induced oscillatory afterpotentials on canine Purkinje fiber.
Endou K, Yamamoto H, Sato T. Endou K, et al. Jpn Heart J. 1987 Sep;28(5):719-35. doi: 10.1536/ihj.28.719. Jpn Heart J. 1987. PMID: 3430732
[Classification of Ca antagonist by its chemical structure and characteristics of each derivative].
Oike M, Xiong ZL, Kuriyama H. Oike M, et al. Nihon Rinsho. 1989 Aug;47(8):1719-27. Nihon Rinsho. 1989. PMID: 2585734 Japanese. No abstract available.
Comparative effects of verapamil, diltiazem and felodipine during experimental digitalis-induced arrhythmias.
Bush LR, Evans RM, Gaul SL, D'Alonzo AJ. Bush LR, et al. Pharmacology. 1987;34(2-3):111-20. doi: 10.1159/000138260. Pharmacology. 1987. PMID: 3588655
Similarities and differences between calcium antagonists: pharmacological aspects.
van Zwieten PA, Pfaffendorf M. van Zwieten PA, et al. J Hypertens Suppl. 1993 Mar;11(1):S3-11. doi: 10.1097/00004872-199303001-00002. J Hypertens Suppl. 1993. PMID: 8483019 Review.
Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
Noll G, Lüscher TF. Noll G, et al. Cardiology. 1998;89 Suppl 1:10-5. doi: 10.1159/000047274. Cardiology. 1998. PMID: 9570424 Review.

See all similar articles

Cited by

How to digitalize and to maintain optimal digoxin levels in congestive heart failure.
Lambert C, Rouleau JL. Lambert C, et al. Cardiovasc Drugs Ther. 1989 Jan;2(6):717-26. doi: 10.1007/BF00133199. Cardiovasc Drugs Ther. 1989. PMID: 2488083 Review.
Clinical pharmacokinetics of vasodilators. Part I.
Kirsten R, Nelson K, Kirsten D, Heintz B. Kirsten R, et al. Clin Pharmacokinet. 1998 Jun;34(6):457-82. doi: 10.2165/00003088-199834060-00003. Clin Pharmacokinet. 1998. PMID: 9646008 Review.
Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
Yukawa E, Suematu F, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y, Aoyama T. Yukawa E, et al. Clin Pharmacokinet. 2001;40(10):773-81. doi: 10.2165/00003088-200140100-00005. Clin Pharmacokinet. 2001. PMID: 11707062

References

1. Am J Cardiol. 1982 Oct;50(4):894-902 - PubMed
1. Clin Nephrol. 1985 Sep;24(3):158-9 - PubMed
1. Int J Clin Pharmacol Biopharm. 1977 Aug;15(8):384-8 - PubMed
1. Am J Cardiol. 1984 May 15;53(10):1480-1 - PubMed
1. Annu Rev Med. 1985;36:357-67 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Miscellaneous
- NCI CPTAC Assay Portal